Nuclear Medicine and Molecular Imaging Applications in Gynecologic Malignancies: A Comprehensive Review
- 11 February 2024
- journal article
- review article
- Published by Elsevier in Seminars in Nuclear Medicine
- Vol. 54 (2) , 270-292
Abstract
No abstract availableKeywords
This publication has 121 references indexed in Scilit:
- Clinical Usefulness of18F-FDG PET/CT in the Detection of Early Recurrence in Treated Cervical Cancer Patients with Unexplained Elevation of Serum Tumor MarkersChonnam Medical Journal, 2013
- The role of FDG-PET/CT in gynaecological cancersCancer Imaging, 2012
- 18F-FDG PET/CT Imaging In OncologyAnnals of Saudi Medicine, 2011
- 18F-FDG PET/CT evaluation of patients with ovarian carcinomaNuclear Medicine Communications, 2008
- Recommendations on the Use of 18F-FDG PET in OncologyJournal of Nuclear Medicine, 2008
- The standardized uptake value for F‐18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survivalCancer, 2007
- The diagnostic value of PET/CT for primary ovarian cancer—A prospective studyGynecologic Oncology, 2007
- Role of positron emission tomography in pretreatment lymph node staging of uterine cervical cancer: A prospective surgicopathologic correlation studyEuropean Journal of Cancer, 2005
- Targeting of HER2 Antigen for the Treatment of Disseminated Peritoneal DiseaseClinical Cancer Research, 2004
- Posttherapy [18F] Fluorodeoxyglucose Positron Emission Tomography in Carcinoma of the Cervix: Response and OutcomeJournal of Clinical Oncology, 2004